BIO-Europe® 2015: Interview with Richard Onyett, ADC Therapeutics

November 19, 2015
Richard Onyett, business development director of ADC Therapeutics, chats with Mike Ward, global director of content for Informa Pharma Insights, about developments in the area of antibody drug conjugates, a field that seems to have been overshadowed by the recent immunotherapy boom. They discuss how the two fields will combine in the future in oncology and where derailed ADC companies went wrong. Find more videos and articles at http://www.partnering360.com/insight For more information on BIO-Europe, visit our webpage: http://www.ebdgroup.com/beu/index.php
Previous Video
BIO-Europe® 2015: Interview with Sander Slootweg, Forbion Capital Partners
BIO-Europe® 2015: Interview with Sander Slootweg, Forbion Capital Partners

Sander Slootweg, managing partner at Forbion Captial Partners, speaks to Mike Ward, global director of cont...

Next Video
BIO-Europe® 2015: Interview with Anthony Walker, Alacrita
BIO-Europe® 2015: Interview with Anthony Walker, Alacrita

Mike Ward, global director of content for Informa Pharma Insights, chats with Anthony Walker, managing part...